CAUTIONARY NOTE TO READERS OF CUBA BUSINESS REPORT RE CUBAN INTERFERON “EFFECTIVE”
A memorandum listing the danger to patients contracting COVID-19 virus who are treated with interferon was sent to Cuba Business Report through its “Contact Us” portal on April 18, 2020, at 4.45 PM. The purpose of the memo was to describe CBR’s column "Cuba’s Interferon Alfa 2b Demonstrates Effectiveness against COVID-19" as knowingly irresponsible reporting of fabricated information that demonstrably has the prospect of increasing morbidity in patients with the disease and increasing mortality.
The memorandum lists just four of numerous reports vigorously cautioning against the use of interferon for the treatment of COVID-19.
For readers of this cautionary note here are a sufficient number of the leading sources of information for conviction that even a superficial search by Cuba Business Report would have surfaced:
The memorandum to CBR cautioned it that patients or their families where interferon has increased morbidity or led to death, may wish to consider recompense from CBR for its knowingly distributing dangerous and materially-misleading information.